SEC 13F Intelligence

Lion Point Capital, LP / EWTX

Lion Point Capital, LP’s Edgewise Therapeutics Inc Position

Does Lion Point Capital, LP own Edgewise Therapeutics Inc (EWTX)? Yes9.1K shares worth $286,650 (+1.71% of its 13F portfolio) as of Q1 2026.

Position Value
$286,650
Q1 2026
Shares
9.1K
% of Portfolio
+1.71%
Quarters Held
2
currently held

Position History EWTX

Reported value by quarter
Q4 ’25: $225,817Q4 ’25Q1 ’26: $286,650Q1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20269.1K$286,650+1.71%
Q4 20259.1K$225,817+1.17%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of EWTX.